Patient identifier - multiple = (b)(6).There was no additional patient information provided by the customer.A review of tickets determined that there is normal complaint activity for alinity creatinine reagent ln 7p99-20 / lot number 53868un20.Trending review determined no trends for discrepant patient results for the product.Return testing was not completed as returns were not available.Retesting of the sample and another sample were reproducible, indicating a possible issue with the initial sample testing.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the alinity creatinine reagent lot number 53868un20 was identified.
|
The customer reported falsely elevated alinity c creatinine results on two patients.The results provided were: on (b)(6) 2020 (b)(6) initial = 6.62mg/dl / retest = 6.78 / after physician questioned retest = 2.63 / new sample, same patient = 1.0 / plasma sample from (b)(6) 2020 = 0.91mg/dl; (b)(6) initial = 5.98 / retest = 4.42mg/dl / after physician questioned = 4.01, 3.99mg/dl / new sample, same patient =0.82mg/dl(normal range male= 0.7 - 1.2, female= 0.5 - 0.9mg/dl).There was no reported impact to patient management.
|